Connecticut 2012 Regular Session

Connecticut Senate Bill SB00436 Compare Versions

OldNewDifferences
11 General Assembly Raised Bill No. 436
22 February Session, 2012 LCO No. 2436
3- *_____SB00436GL____041712____*
3+ *_____SB00436PH____032312____*
44 Referred to Committee on Public Health
55 Introduced by:
66 (PH)
77
88 General Assembly
99
1010 Raised Bill No. 436
1111
1212 February Session, 2012
1313
1414 LCO No. 2436
1515
16-*_____SB00436GL____041712____*
16+*_____SB00436PH____032312____*
1717
1818 Referred to Committee on Public Health
1919
2020 Introduced by:
2121
2222 (PH)
2323
2424 AN ACT CONCERNING PRESCRIPTION DRUG MONITORING.
2525
2626 Be it enacted by the Senate and House of Representatives in General Assembly convened:
2727
2828 Section 1. Section 21a-317 of the general statutes is repealed and the following is substituted in lieu thereof (Effective October 1, 2012):
2929
3030 Every practitioner who distributes, administers or dispenses any controlled substance or who proposes to engage in distributing, prescribing, administering or dispensing any controlled substance within this state shall (1) obtain a certificate of registration issued by the Commissioner of Consumer Protection in accordance with the provisions of this chapter, and (2) register for access to the electronic prescription drug monitoring program, established in accordance with subsection (j) of section 21a-254, in the manner prescribed by the commissioner.
3131
3232
3333
3434
3535 This act shall take effect as follows and shall amend the following sections:
3636 Section 1 October 1, 2012 21a-317
3737
3838 This act shall take effect as follows and shall amend the following sections:
3939
4040 Section 1
4141
4242 October 1, 2012
4343
4444 21a-317
4545
4646
4747
4848 PH Joint Favorable
49-GL Joint Favorable
5049
5150 PH
52-
53-Joint Favorable
54-
55-GL
5651
5752 Joint Favorable